Health
Novo to Test If Obesity Drugs Can Help People Drink Less Alcohol
- Study’s main objective is to measure impact on liver disease
- Novo has already tested weight-loss drugs on heart disease
Ozempic injection pens at the Novo Nordisk production facilities in Hillerod, Denmark.
Photographer: Carsten Snejbjerg/BloombergNovo Nordisk A/S is dipping a toe into research on whether weight-loss drugs can help people drink less alcohol, a field it’s avoided so far as it concentrates on other conditions.
The Danish drugmaker is planning a study whose secondary goal is seeing whether its compounds can change daily alcohol consumption, according to a US government clinical trials registry. The main objective of the mid-stage trial, expected to start recruitment this month, is measuring the drugs’ impact on fibrosis in patients with liver disease.